A
ANAB
Anaptysbio Inc
55.16
-0.54-0.97%Pre Market: 56.26 +1.10 +1.99%04:03 09/11 EDT
OPEN/PREV CLOSE55.43/55.70
TODAY RANGE54.31-56.43
VOL1
MARKET CAP1.63B
52 WEEK RANGE17.97-76.99
AVG VOL (3M)597.12K
% TURNOVER1.01%
TURNOVER0
P/E (TTM)-62.8891
% RANGE3.76%
EPS(TTM)-0.8771
P/E(FORWARD)1,667.47
P/B125.62
BVPS0.4391
DIVIDEND--
P/S6.59
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.54B
SHARES OUTSTANDING29.61M
NEXT EARNINGS11/02-11/06
FREE FLOAT27.93M
LOT SIZE1
EX-DATE04/20/2026
News
Press Releases
Financial Reports
Profile
Dow Jones·2d ago
U.S. Earnings Preview: After Market Close Sept. 8
Simply Wall St·5d ago
AnaptysBio (ANAB) Rides A Royalty Driven Narrative, Is The Stock Still A Bargain?
Dow Jones·09/01 19:30
U.S. Earnings Preview: After Market Close Sept. 1
Simply Wall St·08/28 05:12
Is AnaptysBio (ANAB) Undervalued Or Has Its Royalty Story Already Been Priced In?
Dow Jones·08/25 19:31
U.S. Earnings Preview: After Market Close Aug. 25
Dow Jones·08/25 14:09
AnaptysBio Price Target Cut to $70.00/Share From $75.00 by TD Cowen
Dow Jones·08/25 14:09
AnaptysBio Is Maintained at Buy by TD Cowen
Benzinga·08/25 13:59
TD Cowen Maintains Buy on AnaptysBio, Lowers Price Target to $70
TipRanks·08/25 11:20
AnaptysBio price target lowered to $70 from $75 at TD Cowen
NASDAQ·08/24 15:37
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
Dow Jones·08/24 13:52
AnaptysBio Price Target Maintained With a $95.00/Share by HC Wainwright & Co.
Benzinga·08/24 13:42
HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $95 Price Target
Dow Jones·08/18 19:30
U.S. Earnings Preview: After Market Close Aug. 18
Same Industry
Name/Symbol
Change%
Price